CMC Pharma Consulting BJ ApS: Financial statements 2021
CVR: 41988592
Source: annual report 2021, Danish Business Authority
02/01/2021 – 31/12/2021
CMC Pharma Consulting BJ ApS (CVR 41988592) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,524,020 and a net result of DKK 611,221. Equity in the 2021 report amounted to DKK 651,221. The solvency ratio was 57.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 3,524,020
- Profit/Loss
- DKK 611,221
- Equity
- DKK 651,221
- Total Assets
- DKK 1,137,001
- Employees
- 1
Official annual report
Find more companies like CMC Pharma Consulting BJ ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of January 2, 2021, Babak Jamali is registered as director of CMC Pharma Consulting BJ ApS.
As of January 2, 2021, Babak Jamali is registered as an owner of CMC Pharma Consulting BJ ApS with an ownership share of 100%.
CMC Pharma Consulting BJ ApS was founded on January 2, 2021.
About CMC Pharma Consulting BJ ApS
CMC Pharma Consulting BJ ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2021. The company is registered under the industry Anden teknisk rådgivning. The management consists of Babak Jamali. The company is owned by Babak Jamali. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,764,114 and a net result of DKK 30,653 compared with DKK 127,570 the year before. Equity in the 2025 report amounted to DKK 111,190.